LOSS OF NONPHOSPHORYLATED NEUROFILAMENT IMMUNOREACTIVITY IN TEMPORAL CORTICAL AREAS IN ALZHEIMER'S DISEASE

被引:39
|
作者
Thangavel, R. [1 ]
Sahu, S. K. [1 ,3 ]
Van Hoesen, G. W. [1 ,4 ]
Zaheer, A. [1 ,2 ]
机构
[1] Univ Iowa, Coll Med, Dept Neurol, Iowa City, IA 52242 USA
[2] Vet Affairs Med Ctr, Iowa City, IA 52242 USA
[3] Univ Iowa, Coll Med, Dept Neurosurg, Iowa City, IA 52242 USA
[4] Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA
关键词
Alzheimer's disease; nonphosphorylated neurofilament protein; neurofibrillary tangles; entorhinal cortex; perirhinal cortex; hyperphosphorylated tau protein; MILD COGNITIVE IMPAIRMENT; PREFRONTAL CORTEX AREA-9; NEUROFIBRILLARY TANGLES; PYRAMIDAL NEURONS; SELECTIVE VULNERABILITY; QUANTITATIVE-ANALYSIS; HIPPOCAMPAL-FORMATION; STEREOLOGIC ANALYSIS; MONOCLONAL-ANTIBODY; HUNTINGTONS-DISEASE;
D O I
10.1016/j.neuroscience.2009.02.037
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The distribution of immunoreactive neurons with nonphosphorylated neurofilament protein (SM132) was studied in temporal cortical areas in normal subjects and in patients with Alzheimer's disease (AD). SM132 immunopositive neurons were localized mainly in cortical layers II, III, V and VI, and were medium to large-sized pyramidal neurons. Patients with AD had prominent degeneration of SM132 positive neurons in layers III and V of Brodmann areas 38, 36, 35 and 20; in layers II and IV of the entorhinal cortex (Brodmann area 28); and hippocampal neurons. Neurofibrillary tangles (NFTs) were stained with Thioflavin-S and with an antibody (AT8) against hyperphosphorylated tau. The NFT distribution was compared to that of the neuronal cytoskeletal marker SM132 in these temporal cortical regions. The results showed that the loss of SM132 immunoreactivity in temporal cortical regions of AD brain is paralleled by an increase in NFTs and AT8 immunoreactivity in neurons. The SM132 immunoreactivity was drastically reduced in the cortical layers where tangle-bearing neurons are localized. A strong SM132 immunoreactivity was observed in numerous neurons containing NFTs by double-immunolabeling with SM132 and AT8. However, few neurons were labeled by AT8 and SM132. These results suggest that the development of NFTs in some neurons results from some alteration in SM132 expression, but does not account for all, particularly, early NFT-related changes. Also, there is a clear correlation of NFTs with selective population of pyramidal neurons in the temporal cortical areas and these pyramidal cells are specifically prone to formation of paired helical filaments. Furthermore, these pyramidal neurons might represent a significant portion of the neurons of origin of long corticocortical connection, and consequently contribute to the destruction of memory-related input to the hippocampal formation. Published by Elsevier Ltd on behalf of IBRO.
引用
收藏
页码:427 / 433
页数:7
相关论文
共 50 条
  • [1] LOSS OF NONPHOSPHORYLATED NEUROFILAMENT IMMUNOREACTIVITY, WITH PRESERVATION OF TYROSINE-HYDROXYLASE, IN SURVIVING SUBSTANTIA-NIGRA NEURONS IN PARKINSONS-DISEASE
    GAI, WP
    VICKERS, JC
    BLUMBERGS, PC
    BLESSING, WW
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (09): : 1039 - 1046
  • [2] Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease
    Allen, SJ
    Wilcock, GK
    Dawbarn, D
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 264 (03) : 648 - 651
  • [3] Early neurone loss in Alzheimer's disease: cortical or subcortical?
    Arendt, Thomas
    Brueckner, Martina K.
    Morawski, Markus
    Jaeger, Carsten
    Gertz, Hermann-Josef
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2015, 3 : 10
  • [4] Early neurone loss in Alzheimer’s disease: cortical or subcortical?
    Thomas Arendt
    Martina K Brückner
    Markus Morawski
    Carsten Jäger
    Hermann-Josef Gertz
    Acta Neuropathologica Communications, 3
  • [5] A MONOCLONAL-ANTIBODY TO NONPHOSPHORYLATED NEUROFILAMENT PROTEIN MARKS THE VULNERABLE CORTICAL-NEURONS IN ALZHEIMERS-DISEASE
    MORRISON, JH
    LEWIS, DA
    CAMPBELL, MJ
    HUNTLEY, GW
    BENSON, DL
    BOURAS, C
    BRAIN RESEARCH, 1987, 416 (02) : 331 - 336
  • [6] Presenilin immunoreactivity in Alzheimer's disease
    Panegyres, PK
    Toufexis, K
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (09) : 700 - 706
  • [7] Weight loss and Alzheimer's disease: temporal and aetiologic connections
    Sergi, Giuseppe
    De Rui, Marina
    Coin, Alessandra
    Inelmen, Emine Meral
    Manzato, Enzo
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2013, 72 (01) : 160 - 165
  • [8] The thickness of posterior cortical areas is related to executive dysfunction in Alzheimer's disease
    Vasconcelos, Luciano de Gois
    Jackowski, Andrea Parolin
    de Oliveira, Maira Okada
    Ribeiro Flor, Yona Mayara
    Lino Souza, Altay Alves
    Amodeo Bueno, Orlando Francisco
    Dozzi Brucki, Sonia Maria
    CLINICS, 2014, 69 (01) : 28 - 37
  • [9] Spatial and temporal patterns of cortical mean diffusivity in Alzheimer's disease and suspected non-Alzheimer's disease pathophysiology
    Sun, Pan
    He, Zhengbo
    Li, Anqi
    Yang, Jie
    Zhu, Yalin
    Cai, Yue
    Ma, Ting
    Ma, Shaohua
    Guo, Tengfei
    ALZHEIMERS & DEMENTIA, 2024, 20 (10) : 7048 - 7061
  • [10] The Potential of Neurofilament Light as a Biomarker in Alzheimer's Disease
    Xiong, Yong-lan
    Meng, Tao
    Luo, Jing
    Zhang, Hua
    EUROPEAN NEUROLOGY, 2021, 84 (01) : 6 - 15